Citations

Showing 10 of 108094 citations.

Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions
Räber, Lorenz , Mintz, Gary S. , Koskinas, Konstantinos C. , Johnson, Tom , Onuma, Yoshinubo, Radu, Maria , Joner, Michael , Jia, Haibo , Méneveau, Nicolas , Hernández, José M. de la Torre , Escaned, Javier , Hill, Jonathan , Prati, Francesco , Colombo, Antonio , Regar, Evelyn , Wijns, William , Byrne, Robert A. , Guagliumi, Giulio , Group, ESC Scientific Document, Alfonso, Fernándo , Bhindi, Ravinay, Ali, Ziad A. , Carter, Rickey E. , Joner, Michael , Onuma, Yoshinobu , Carter, Rickey E , Onuma, Yoshinobu , Holm, Niels Ramsing , Yu, Bo , Mario, Carlo Di , Capodanno, Davide , Group, ESC Scientific Document, Escaned, Javier , Wijns, William , Räber, Lorenz

Mayo Clinic

European Heart Journal | May 16, 2018 | Volume: 39 | Issue: 35 | Pages: 3281-3300

10.1093/eurheartj/ehy285 | PMID 29790954 Get It

Abstract This Consensus Document is the first of two reports summarizing the views of an expert panel organized by the European Association of Percutaneous Cardiovascular Interventions (EAPCI) on the clinical use of intracoronary imaging including intravascular ultrasound (IVUS) and optical coherence tomography (OCT). The first document appraises the role of intracoronary imaging to guide percutaneous coronary interventions (PCIs) in clinical practice. Current evidence regarding the impact of intracoronary imaging guidance on cardiovascular outcomes is summarized, and patients or lesions most likely to derive clinical benefit from an imaging-guided intervention are identified. The relevance of the use of IVUS or OCT prior to PCI for optimizing stent sizing (stent length and diameter) and planning the procedural strategy is discussed. Regarding post-implantation imaging, the consensus group recommends key parameters that characterize an optimal PCI result and provides cut-offs to guide corrective measures and optimize the stenting result. Moreover, routine performance of intracoronary imaging in patients with stent failure (restenosis or stent thrombosis) is recommended. Finally, strengths and limitations of IVUS and OCT for guiding PCI and assessing stent failures and areas that warrant further research are critically discussed.
The Spectrum of Surgical Remediation of Transoral Incisionless Fundoplication-Related Failures
Puri, Ruchir , Smith, C. Daniel, Bowers, Steven P.

Mayo Clinic

Journal of Laparoendoscopic & Advanced Surgical Techniques | May 16, 2018 | Volume: 28 | Issue: 9 | Pages: 1089-1093

10.1089/lap.2018.0063 | PMID 29768079 Get It

Application of the AAST EGS Grade for Adhesive Small Bowel Obstruction to a Multi‐national Patient Population
Birindelli, Arianna , Bruce, John , Buitendag, Johannes, Kong, Victor , Beuran, Mircea , Aho, Johnathon M. , Negoi, Ionuţ , Clarke, Damian , Saverio, Salomone Di , Zielinski, Martin D. , Hernandez, Matthew C.

Mayo Clinic

World Journal of Surgery | May 16, 2018 | Volume: 42 | Issue: 11 | Pages: 3581-3588

10.1007/s00268-018-4671-1 | PMID 29770872 Get It

AbstractBackgroundThe American Association for the Surgery of Trauma (AAST) anatomic severity grading system for adhesive small bowel obstruction (ASBO) has demonstrated to be a valid tool in North American patient populations. Using a multi‐national patient cohort, we retrospectively assessed the validity the AAST ASBO grading system and estimated disease severity in a global population in order to correlate with several key clinical outcomes.MethodsMulticenter retrospective review during 2012–2016 from four centers, Minnesota USA, Bologna Italy, Pietermaritzburg South Africa, and Bucharest Romania, was performed. Adult patients (age ≥ 18) with ASBO were identified. Baseline demographics, physiologic parameters, laboratory results, operative and imaging details, outcomes were collected. AAST ASBO grades were assigned by independent reviewers. Univariate and multivariable analyses with odds ratio (OR) and 95% confidence intervals (CIs) were performed.ResultsThere were 789 patients with a median [IQR] age of 58 [40–75] years; 47% were female. The AAST ASBO grades were I (n = 180, 23%), II (n = 443, 56%), III (n = 87, 11%), and IV (n = 79, 10%). Successful non‐operative management was 58%. Conversion rate from laparoscopy to laparotomy was 33%. Overall mortality and complication and temporary abdominal closure rates were 2, 46, and 4.7%, respectively. On regression, independent predictors for mortality included grade III (OR 4.4 95%CI 1.1–7.3), grade IV (OR 7.4 95%CI 1.7–9.4), pneumonia (OR 5.6 95%CI 1.4–11.3), and failing non‐operative management (OR 2.4 95%CI 1.3–6.7).ConclusionThe AAST EGS grade can be assigned with ease at any surgical facility using operative or imaging findings. The AAST ASBO severity grading system has predictive validity for important clinical outcomes and allows for standardization across institutions, providers, and future research. Disease severity and outcomes varied between countries.Level of evidence IIIStudy type Retrospective multi‐institutional cohort study.
Romiplostim for the management of perioperative thrombocytopenia
Al‐Samkari, Hanny , Marshall, Ariela L. , Goodarzi, Katayoon, Kuter, David J. , Marshall, Ariela , Al-Samkari, Hanny

Mayo Clinic

British Journal of Haematology | May 16, 2018 | Volume: 182 | Issue: 1 | Pages: 106-113

10.1111/bjh.15280 | PMID 29767837 Get It

SummaryThrombocytopenic patients requiring invasive surgery have few options to improve their platelet count preoperatively. This is a single‐centre, retrospective review of thrombocytopenic patients receiving the thrombopoietin receptor agonist romiplostim perioperatively to allow for surgical interventions. Patient characteristics, romiplostim use, and surgical and safety outcomes (bleeding, thrombosis, transfusions) were collected and analysed. Forty‐seven patients underwent 51 surgical procedures (ranging from total hip arthroplasty to open cardiac surgery) with romiplostim support. Thrombocytopenia aetiologies included immune thrombocytopenia, chronic liver disease, haematological malignancy, drug‐related thrombocytopenia, and hereditary thrombocytopenia. Median (range) platelet counts improved, from 47 × 109/l (9–120 × 109/l) at romiplostim initiation to 164 × 109/l (28–603 × 109/l) at the time of surgery (P < 0·0001). A dose of 3 μg/kg per week for 2 doses increased the platelet count to >100 × 109/l in 79% of patients within 14 days. In 96% of cases, surgery proceeded on schedule without delay or cancellation. Four patients had bleeding events unrelated to thrombocytopenia and 1 patient developed deep venous thrombosis. Six patients required red cell transfusion and 3 patients required platelet transfusion perioperatively. In conclusion, romiplostim was effective in increasing platelet counts to allow surgery to proceed safely and on schedule. Bleeding and thromboembolic events were within acceptable limits for this surgical population.
The Underestimated Burden of Monogenic Diseases in Adult-Onset ESRD
Gall, Émilie Cornec-Le , Harris, Peter C. , Harris, Peter C , Cornec-Le Gall, Emilie

Mayo Clinic

Journal of the American Society of Nephrology | May 16, 2018 | Volume: 29 | Issue: 6 | Pages: 1583-1584

10.1681/asn.2018040441 | PMID 29769229 Get It

Right Ventricular Dysfunction and Long-Term Risk of Sudden Cardiac Death in Patients With and Without Severe Left Ventricular Dysfunction
Naksuk, Niyada , Tan, Nicholas Y. , Padmanabhan, Deepak , Kancharla, Krishna , Makkar, Nayani , Yogeswaran, Vidhushei , Gaba, Prakriti , Kaginele, Pranita , Riley, David C., Sugrue, Alan , Rosenbaum, Andrew , El‐Harasis, Majd , Asirvatham, Samuel J. , Asirvatham, Samuel J , Kapa, Suraj , McLeod, Christopher J.

Mayo Clinic

Circulation: Arrhythmia and Electrophysiology | May 16, 2018 | Volume: 11 | Issue: 6 | Pages: No page available

10.1161/circep.117.006091 | PMID 29769224 Get It

Background: Right ventricular systolic dysfunction (RVD) often coexists with various cardiopulmonary diseases. However, the association between RVD and risk of sudden cardiac death (SCD) has not been well studied. This study examined the risk of SCD associated with RVD in patients with heterogeneous underlying cardiac diseases. Methods: The Mayo Clinic cardiac care unit database included 5463 consecutive patients with complete echocardiographic evaluation to assess right ventricular systolic function and RVD severity. Prospective surveillance follow-up was obtained for all patients. SCD was adjudicated when a malignant ventricular arrhythmia was documented as the primary rhythm leading to death. RESULTS: The prevalence of mild RVD and moderate-severe RVD was 14.9% and 17.1%, respectively. Patients with RVD were more likely to have a history of congestive heart failure, cardiac arrest, pulmonary disease, and lower baseline left ventricular ejection fraction compared with those with normal right ventricular systolic function. During a median follow-up of 14 months, the incidence of SCD was highest in patients with moderate-severe RVD (7.4% versus 4.4% in mild RVD versus 1.6% in normal right ventricular function; P <0.001). After adjustment for baseline characteristics, mild RVD (adjusted hazard ratio, 1.57; P =0.046) and moderate-severe RVD (adjusted hazard ratio, 1.91; P =0.006) were independently associated with an increased risk of SCD. Moderate-severe RVD remained an independent predictor of SCD for patients with left ventricular ejection fraction >35% without or with preexisting implantable cardioverter-defibrillator (adjusted hazard ratio, 4.12; P =0.003 and adjusted hazard ratio, 5.04; P <0.001, respectively). Conclusions: Presence of RVD in patients with a history of preexisting cardiac disease is an independent predictor of SCD irrespective of left ventricular ejection fraction.
Relative Intake of Macronutrients Impacts Risk of Mild Cognitive Impairment or Dementia
Roberts, Rosebud O., Roberts, Lewis A., Geda, Yonas E. , Cha, Ruth H., O’Connor, Helen M. , Petersen, Ronald C. , Geda, Yonas E , Cha, Ruth H., Pankratz, V. Shane , Knopman, David S.

Mayo Clinic

Journal of Alzheimer's Disease | May 16, 2018 | Volume: 32 | Issue: 2 | Pages: 329-339

10.3233/jad-2012-120862 | PMID 22810099 Get It

Characterization of Insulin Degrading Enzyme and Other Amyloid-β Degrading Proteases in Human Serum: A Role in Alzheimer's Disease?
Liu, Zhiheng , Zhu, Haihao , Fang, Guang, Walsh, Kathryn, Mwamburi, Mkaya, Abdul‐Hay, Samer O., Ikezu, Tsuneya , Leissring, Malcolm A. , Ikezu, Tsuneya , Wolozin, Benjamin , Qiu, Wei Qiao

Mayo Clinic

Journal of Alzheimer's Disease | May 16, 2018 | Volume: 29 | Issue: 2 | Pages: 329-340

10.3233/jad-2011-111472 | PMID 22232014 Get It

The Role of Variation at AβPP, PSEN1, PSEN2, and MAPT in Late Onset Alzheimer's Disease
Gerrish, Amy , Russo, Giancarlo , Richards, Alexander , Moskvina, Valentina, Ivanov, Dobril , Harold, Denise , Sims, Rebecca , Abraham, Richard, Hollingworth, Paul, Chapman, Jade , Hamshere, Marian L. , Pahwa, Jaspreet Singh, Dowzell, Kimberley, Jones, Nicola, Thomas, Charlene , Stretton, Alexandra, Morgan, Angharad R., Lovestone, Simon , Powell, John , Proitsi, Petroula , Brayne, Carol , Gill, Michael , Lynch, Aoibhinn, Morgan, Kevin , Brown, Kristelle, Passmore, Peter , Craig, David W. , McGuinness, Bernadette , Todd, Stephen , Johnston, Janet, Smith, A. David , Love, Seth , Kehoe, Patrick G. , Hardy, John , Mead, Simon , Fox, Nick C. , Rossor, Martin N. , Collinge, John, Maier, Wolfgang, Jessen, Frank , Kölsch, Heike, Schürmann, Britta, Bussche, Hendrik van den, Heuser, Isabella , Kornhuber, Johannes , Wiltfang, Jens , Dichgans, Martin , Frölich, Lutz, Hampel, Harald , Hüll, Michael, Goate, Alison , Kauwe, John, Cruchaga, Carlos , Nowotny, Petra, Morris, John C. , Mayo, Kevin H. , Livingston, Gill , Gurling, Hugh, McQuillin, Andrew , Gwilliam, Rhian, Deloukas, Panagiotis, Davies, Gail , Starr, John M. , Deary, Ian J. , Al‐Chalabi, Ammar , Shaw, Christopher E. , Tsolaki, Magda , Singleton, Andrew B., Guerreiro, Rita , Mühleisen, Thomas W. , Nöthen, Markus M. , Moebus, Susanne , Jöckel, Karl‐Heinz , Klopp, Norman, Wichmann, H‐Erich, Carrasquillo, Minerva M., Younkin, Steven G., Jones, Lesley , Holmans, Peter , O‘Donovan, Michael , Williams, Julie , Deloukas, Panos , Escott‐Price, Valentina , Denning, Nicola , Dichgans, Martin , Cruchaga, Carlos , Kornhuber, Johannes , Nöthen, Markus M , Hardy, John , Moebus, Susanne , Williams, Amy L. , Lupton, Michelle K. , Rubinsztein, David Chaim , LAWLOR, BRIAN A. , Holmes, Clive , Mann, David , Heun, Reinhard , Rujescu, Dan , Bass, Nicholas , Harris, Sarah , Carrasquillo, Minerva M. , Pankratz, V. Shane , Owen, Michael J. , Fox, Nick C , Morris, John C , Wiltfang, Jens , Al-Chalabi, Ammar , Tsolaki, Magda , Goate, Alison M , McQuillin, Andrew , Escott-Price, Valentina

Mayo Clinic

Journal of Alzheimer's Disease | May 16, 2018 | Volume: 28 | Issue: 2 | Pages: 377-387

10.3233/jad-2011-110824 | PMID 22027014 Get It

Plasma Sphingomyelins are Associated with Cognitive Progression in Alzheimer's Disease
Mielke, Michelle M. , Bandaru, Veera Venkata Ratnam, Weinberg, Danielle , Darby, Eveleen, Zaidi, Noman, Pavlik, Valory , Doody, Rachelle S., Lyketsos, Constantine G. , Donohue, Michael , Mielke, Michelle M , Haughey, Norman J. , Donohue, Michael C

Mayo Clinic

Journal of Alzheimer's Disease | May 16, 2018 | Volume: 27 | Issue: 2 | Pages: 259-269

10.3233/jad-2011-110405 | PMID 21841258 Get It